S
Stefan K. Nilsson
Researcher at Umeå University
Publications - 69
Citations - 10244
Stefan K. Nilsson is an academic researcher from Umeå University. The author has contributed to research in topics: Adipose tissue & Estrogen receptor. The author has an hindex of 30, co-authored 62 publications receiving 9740 citations. Previous affiliations of Stefan K. Nilsson include University of Hamburg.
Papers
More filters
Journal ArticleDOI
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
George G.J.M. Kuiper,Bo Carlsson,Kaj Grandien,Eva Enmark,Johan Häggblad,Stefan K. Nilsson,Jan-Åke Gustafsson +6 more
TL;DR: The messenger RNA expression of both ER subtypes in rat tissues by RT-PCR is investigated and the ligand binding specificity of the ER sub types is compared, revealing a single binding component for 16β-estradiol with high affinity.
PatentDOI
DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ER$g(a) AND ER$g(b) AT AP1 SITES
Peter J. Kushner,Jan-Ake Gustafsson,George G.J.M. Kuiper,Stefan K. Nilsson,Kolja Paech,Thomas S. Scanlan,Paul W. Webb +6 more
TL;DR: In this article, a cell comprising an estrogen receptor beta (ER beta ), AP1 proteins, and a construct comprising a promoter comprising an AP1 site which regulates expression of a first reporter gene is contacted with the test compound and changes in expression levels of the reporter gene are detected indicating whether the test compounds activate transcription, inactivate transcription or have no effect at the AP1 sites.
Journal ArticleDOI
A role for estrogen receptor β in the regulation of growth of the ventral prostate
Zhang Weihua,Sari Mäkelä,Sari Mäkelä,Leif C. Andersson,Leif C. Andersson,Saija Salmi,Shigehira Saji,Jeanette I Webster,Elwood V. Jensen,Stefan K. Nilsson,Margaret Warner,Jan-Ake Gustafsson +11 more
TL;DR: Findings suggest that ligands specific for ERβ may be useful in the prevention and/or clinical management of prostatic hyperplasia and neoplasia.
Journal ArticleDOI
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.
Roland Klingenberg,Norbert Gerdes,Robert M. Badeau,Anton Gisterå,Daniela Strodthoff,Daniel F. J. Ketelhuth,Anna M. Lundberg,Mats Rudling,Stefan K. Nilsson,Gunilla Olivecrona,Stefan Zoller,Christine Lohmann,Thomas F. Lüscher,Matti Jauhiainen,Tim Sparwasser,Göran K. Hansson +15 more
TL;DR: In this article, the authors support the use of regulatory T cells (Tregs) as inhibitors of atherosclerosis, however, the mechanistic properties of Tregs are unknown.
Depletion of FOXP3(+) regulatory T cells promotes hypercholesterolemia and atherosclerosis
Roland Klingenberg,Norbert Gerdes,Robert M. Badeau,Anton Gisterå,Daniela Strodthoff,Daniel F. J. Ketelhuth,Anna M. Lundberg,Mats Rudling,Stefan K. Nilsson,Gunilla Olivecrona,Stefan Zoller,Christine Lohmann,Thomas F Luescher,Matti Jauhiainen,Tim Sparwasser,Göran K. Hansson +15 more
TL;DR: It is demonstrated that FOXP3(+) Tregs inhibit atherosclerosis by modulating lipoprotein metabolism by mediating the altered lipid phenotype.